Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cradle logo — Engineer better proteins, faster.

Cradle

Engineer better proteins, faster.

Founded 2021 The Netherlands The Netherlands 134 employees Series B Total: $102.50M AI, Biotechnology +1

General Information

Company Name Cradle
Founded Year 2021
Location The Netherlands The Netherlands +2
Founders / Decision Makers
Team member Team member
Employees 134
Industries AI, Biotechnology, Pharmaceutical
Funding Stage Series B
Social

Get notified when Cradle moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Major Customer Win Sep 16, 2026

IFF is highlighted as a customer, with Luis Cascão Pereira praising Cradle's system for democratizing enzyme engineering capabilities and accelerating R&D.

Event Participation Sep 16, 2026

The company Cradle is welcomed back to participate in the event Synbiobeta2027.

Get alerts when Cradle shows new signals

AI Insight

Bounce Watch AI
1 month ago

Cradle is undergoing significant post-Series B growth and strategic development, marked by aggressive hiring for 68 positions and the expansion of its lab facilities to boost R&D capacity. Further solidifying its market position, the company has joined the Atlas Consortium alongside key industry players, including GSK, to collaboratively address critical data bottlenecks in AI protein engineering. This concerted effort underscores a dual focus on internal scaling and external strategic partnerships to drive innovation and leadership in the biopharmaceutical sector.

Signal Types
Hiring Expansion Partnership
Strategic Labels
Team Growth R&D Scaling Industry Collaboration
Next Move: Scaling
·
Impact: 8/10
·
Ideal For: Growth-stage Biotech Investors – Series B/C

About Cradle

Cradle, founded in 2021, is gaining traction in the intersection of AI, Biotechnology, and Pharmaceutical industries. Based in The Netherlands, the company promises to "Engineer better proteins, faster." By leveraging AI technology, Cradle aims to generate protein candidates and enhance their properties, thus achieving breakthroughs with fewer experiments guided by personalized experimental data.

With a notable Series B investment of $73.00M closed on 01 November 2024, Cradle has secured financial backing from prominent investors such as Kindred Capital, Index Ventures, and IVP. These investments underline the confidence of leading venture firms in Cradle's innovative application of AI to protein engineering.

The company is poised for growth as it continues to disrupt traditional processes of protein development, positioning itself as a key player in its industry spaces.

Taxonomy: biotech company, protein design, AI design recommendations, intellectual property ownership, machine learning platform, therapeutics development, bio-based products, enzymes, antibodies, pharmaceutical applications, industrial applications, protein engineering, protein activity optimization, protein stability enhancement, protein solubility improvement

Services & Products

Protein Engineering Optimization
AI-Driven Experimental Design
Custom Model Evaluation and Integration

Target Customers

Biopharmaceutical Companies Industrial Biotechnology Researchers R&D Teams in Biotech Therapeutics Developers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 3
Investor Investor Investor
01 Nov 2024
Series A •••••• 1
Investor
01 Nov 2023
Seed •••••• 10
Investor Investor Investor
•••• •••• 		01 Nov 2022

Latest News

View All
Cradle’s AI-powered protein programming platform levels up with $24M in new funding — Techcrunch
Cradle’s AI-powered protein programming platform levels up with $24M in new funding
Techcrunch Jan 23, 2024
Dutch biotech startup bags €22M for proprietary generative AI model — Thenextweb
Dutch biotech startup bags €22M for proprietary generative AI model
Thenextweb Jan 23, 2024
Cradle raises $24M to expand Generative AI for protein design and engineering — Tech
Cradle raises $24M to expand Generative AI for protein design and engineering
Tech Jan 23, 2024
GenAI biotech Cradle raises $24m Series A led by Index Ventures — Sifted
GenAI biotech Cradle raises $24m Series A led by Index Ventures
Sifted Jan 23, 2024
19 AI healthtechs to watch, according to VCs — Sifted
19 AI healthtechs to watch, according to VCs
Sifted Apr 05, 2024
This week in Dutch tech — Thenextweb
This week in Dutch tech
Thenextweb May 24, 2024

Cradle Alternatives & Competitors

View All Alternatives
Cradle vs
RevolKa Ltd.
RevolKa Ltd. Japan

Contribute to the health and well-being of people by using our innovative AI assisted protein engine...

11 employees
Cradle vs
Vivici
Vivici The Netherlands

Superior dairy proteins with significantly less impact on the planet.

Not Funded/Unknown
33 employees
Cradle vs
GenScript ProBio
GenScript ProBio

A comprehensive R&D and production platform offering complete solutions for cell and gene therapy, v...

Series C
1001-5000 employees
Biopharma, Pharmaceutical
Compare Cradle vs GenScript ProBio
Also compare with: Cradle vs Loopworm Loopworm Cradle vs Recbio Recbio View all alternatives

FAQ About Cradle

Engineer better proteins, faster.
Cradle was founded in 2021.
Cradle is headquartered in The Netherlands.
Cradle operates in the following industries: AI, Biotechnology, Pharmaceutical.
Cradle has approximately 134 employees.
Cradle has completed 3 funding rounds, raising a total of $102.50M. The latest funding stage is Series B.
Cradle offers: Protein Engineering Optimization, AI-Driven Experimental Design, Custom Model Evaluation and Integration.
Top alternatives and competitors to Cradle include RevolKa Ltd., Vivici, GenScript ProBio, Loopworm, Accelagen. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cradle and RevolKa Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cradle and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy